ABSTRACT
The involvement of the multi-drug-resistant 1 P-glycoprotein gene (MDR1 P-gp) in the transport of antidepressants across the blood–brain barrier makes it a good candidate for the prediction of antidepressant response and side effects. We investigated the role of the MDR1 P-gp gene in predicting the induction of mania in bipolar patients (BP) treated with proserotonergic drugs. Participants met the DSM-IV criteria for BP or BPII and had at least one depressive episode treated with proserotonergic antidepressants. The first group (n=26) included patients with at least one DSM-IV manic/hypomanic episode developed during antidepressant treatment; the second group (N=29) included patients with no antidepressant-induced switches. The common polymorphism of the MDR1 was genotyped for both groups and comparison was made with respect to the presence/absence of induced mania between the two groups. No association between antidepressant-induced mania and the MDR1 alleles or genotypes was found (χ2=1.85, 2 df, P=0.39; χ2=0.13, 1 df, P=0.72).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM . Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1998; 39: 361–398.
Uhr M, Steckler T, Yassouridis A, Holsboer F . Penetration of amitriptyline, but not of aluoxetine, into brain is enhanced in mice with blood–brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 2000; 22: 380–387.
McGuffin P, Katz R . The genetics of depression and manic-depressive disorder. Br J Psychiatry 1989; 155: 294–304.
Gershon ES . Genetics. In: Goodwin FK, Jamison KR (eds). Manic-Depressive Illness. Oxford University Press: New York, NY 1990; pp 373–401.
Nurnberger Jr JI, Gershon ES . Genetics. In: Paykel ES (ed). Handbook of Affective Disorders. Churchill Livingstone Inc.: New York, NY 1992; pp 131–148.
Hoffmeyer S, Burk O, Richter OV, Arnold HP, Brockmoller J, Johne A et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–3478.
Verstuyft C, Schwab M, Schaeffeler E, Kerb R, Brinkmann U, Jaillon P et al. Digoxin pharmacokinetics and MDR1 genetic polymorphisms. Eur J Clin Pharmacol 2003; 58: 809–812.
Kim RB, Leake BF, Choo EF, Dresser GK, Kubba SV, Schwartz UI et al. Identification of functionally variant MDR1 alleles among European Americans and Americans. Clin Pharmacol Ther 2001; 70: 189–199.
Drescher S, Schaeffeler E, Hitzl M, Hofmann U, Schwab M, Brinkmann U et al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 2002; 53: 526–534.
Hitzl M, Drescher S, van der Kuip H, Schaffeler E, Fischer J, Schwab M et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56(+) natural killer cells. Pharmacogenetics 2001; 11: 293–298.
Morita Y, Sakaeda T, Horinouchi M, Nakamura T, Kuroda K, Miki I et al. MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects. Pharm Res 2003; 20: 552–556.
Roberts R, Joyce P, Mulder R, Begg E, Kennedy MA . A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated with major depression. Pharmacogenomics J 2002; 2: 191–196.
Wehr TA, Goodwin FK . Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144: 1403–1411.
Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L . Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130–1138.
Howland RH . Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996; 16: 425–427.
Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL . Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry 1998; 59: 374–379.
Angst J . Switch from depression to mania: a record survey over decades between 1920 and 1982. Psychopathology 1985; 18: 140–154.
Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL . The role of serotonin transporter gene in antidepressant-induced mania in bipolars. Arch Gen Psychiatry 2000; 47(Suppl): 135S.
Lahiri DK, Nurnberger JI . A rapid no-enzymatic method for the preparation of HMW DNA from blood for RFLP analysis. Nucleic Acids Res 1991; 19: 5444.
Tang K, Ngoi S, Gwee P, Chua JMZ, Lee EJD, Chong SS et al. Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations. Pharmacogenetics 2002; 12: 437–450.
Coryell W, Endicott J, Keller M . Rapid cycling affective disorder: demographics, diagnosis, family history and course. Arch Gen Psychiatry 1992; 49: 126–131.
Mahar Doan KM, Humphreys JE, Webster LO, Wring SA, Shampine LJ, Serabjit-Singh CJ et al. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs. J Pharmacol Exp Therap 2002; 303: 1029–1037.
Uhr M, Grauer MT, Holsboer F . Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry, Print copy in press (original) published online May 3, 2003, at http://www-east.elsevier.com/bps/prepub.htm).
Uhr M, Grauer MT . abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice. J Psychiatr Res 2003; 37: 179–185.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
De Luca, V., Mundo, E., Trakalo, J. et al. Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania. Pharmacogenomics J 3, 297–299 (2003). https://doi.org/10.1038/sj.tpj.6500196
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500196
Keywords
This article is cited by
-
Pharmacogenetics and Imaging–Pharmacogenetics of Antidepressant Response: Towards Translational Strategies
CNS Drugs (2016)
-
ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder
The Pharmacogenomics Journal (2013)
-
ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research
The Pharmacogenomics Journal (2007)
-
ABC drug transporter at the blood–brain barrier
European Archives of Psychiatry and Clinical Neuroscience (2006)